Molecular and cellular mechanisms underlying the therapeutic effects of budesonide in asthma
- 1 October 2016
- journal article
- review article
- Published by Elsevier in Pulmonary Pharmacology & Therapeutics
- Vol. 40, 15-21
Abstract
No abstract availableKeywords
This publication has 59 references indexed in Scilit:
- Multiple In Vitro and In Vivo Regulatory Effects of Budesonide in CD4+ T Lymphocyte Subpopulations of Allergic AsthmaticsPLOS ONE, 2012
- What effect does asthma treatment have on airway remodeling? Current perspectivesJournal of Allergy and Clinical Immunology, 2011
- Biochemical Basis of Asthma TherapyJournal of Biological Chemistry, 2011
- Airway remodeling in asthmaCurrent Opinion in Pharmacology, 2010
- A new look at the pathogenesis of asthmaClinical Science, 2009
- The cytokine network in asthma and chronic obstructive pulmonary diseaseJournal of Clinical Investigation, 2008
- Glucocorticoids Regulate Tristetraprolin Synthesis and Posttranscriptionally Regulate Tumor Necrosis Factor Alpha Inflammatory SignalingMolecular and Cellular Biology, 2006
- MAP kinase phosphatase 1: a novel mediator of biological effects of glucocorticoids?Journal of Endocrinology, 2003
- Relationship between lung tissue and blood plasma concentrations of inhaled budesonideBiopharmaceutics & Drug Disposition, 1993
- BudesonideDrugs, 1992